Skip to main content

HomeResearchCompareCerluten vs MOTS-c

Peptide Comparison

Cerluten vs MOTS-c

Both are Longevity & Cellular peptides.

Cerluten

brain peptide bioregulator

LongevityResearch Only

1 providers listed

Full Cerluten profile →
vs

MOTS-c

Mitochondrial ORF of the 12S rRNA type-c

LongevityAdvisory Vote: FavorableResearch Only

Half-life: Unknown (rapidly cleared from plasma)

185 providers listed

Full MOTS-c profile →
Bottom line

MOTS-c carries stronger published evidence (Cohort study, 8 key studies) than Cerluten (Review, 2); both are research compounds.

Quick Verdict

Cerluten

MOTS-c

Which One Should You Choose?
Your goalBetter option
Stronger clinical evidenceMOTS-c
Oral administration optionCerluten
More provider options (1 vs 185)MOTS-c

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison
Cerluten
MOTS-c
Mechanism Family
Longevity & Cellular
Longevity & Cellular
Half-life
Unknown (rapidly cleared from plasma)
FDA Status
unknown
advisory committee recommended
Admin Routes
oral, subcutaneous
subcutaneous, intravenous
Availability
Research Only
Research Only
Providers
1 listed
185 listed
FDA Update
Jul 2026
Avail. Notes
Mitochondria-derived peptide encoded in 12S rRNA. Regulates metabolism and exercise capacity. No FDA approval, no NDA or IND. Pure research compound; no clinical development program.
Research Evidence

Cerluten

Review · 2 key studies · most recent 2022

MOTS-c

Cohort study · 8 key studies · most recent 2026
Research Citations

About Cerluten

CNS-targeted peptide complex that modulates neuronal gene expression. Shown in Russian clinical studies to improve memory consolidation, attention, and protect against neurodegeneration.

Research Areas
neuroprotectioncognitive supportmemoryanti-aginglongevity

About MOTS-c

Mitochondria-derived peptide that translocates to nucleus under stress; activates AMPK pathway, regulates AICAR and folate-methionine cycle

Research Areas
metabolic regulationinsulin sensitivityexercise mimicryanti-aging
Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Cerluten

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

MOTS-c

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Price (per mg)

Cerluten

Not enough vendor pricing yet.

MOTS-c

$4.93/mg

$3.03$6.96 range

51 vendors

Find Providers

Where to source these peptides

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Longevity & Cellular Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated August 26, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Cerluten vs MOTS-c — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/cerluten/mots-c

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.